✦ LIBER ✦

Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients

✍ Scribed by Paul Sandor; Brian Baker; Jane Irvine; Paul Dorian; D. McKessok; S. Mendlowitz

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1091-4269
DOI: 10.1002/(sici)1520-6394(1998)7:2<69::aid-da3>3.0.co;2-0

No coin nor oath required. For personal study only.

✦ Synopsis

It has been suggested that serotonin reuptake inhibitors (SSRIs) may be less effective than tricyclic antidepressants (TCAs) in treatment of melancholic depression. We treated 36 depressed ambulatory patients with doxepin or fluoxetine in a double-blind, randomized 6-week trial with placebo run-in. Seven patients treated with doxepin and 13 patients treated with fluoxetine met diagnostic criteria for melancholic depression. Average daily dose was 169.4 ± 41.6 mg for doxepin and 36.8 ± 18 mg for fluoxetine. We observed a 50% response rate in both treatment groups, using as outcome criterion reduction of Hamilton Depression Scale Score to less than 10. Regardless of how strict the definition of response, we found fluoxetine to be as effective as doxepin in our group of melancholic outpatients.

📜 SIMILAR VOLUMES

Fluoxetine treatment of depression in pa

Fluoxetine treatment of depression in patients suffering from multiple sclerosis

✍ Yoram Barak; Anat Achiron; David Shoshani; Avner Elizur 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Study of haemostasis in depressive patie

Study of haemostasis in depressive patients treated with fluoxetine

✍ Pascale Lainé-Cessac; Iran Shoaay; Jean-Bernard Garre; Valerie Glaud; Alain Turc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

The object of this study was to investigate a possible pharmacological eect of ¯uoxetine on haemostatic function, with special attention on primary haemostasis, in order to explain haemorrhagic complications reported in some treated, depressed patients. The haemostatic function of depressive patient

The effects of fluoxetine and dothiepin

The effects of fluoxetine and dothiepin on cognitive function in depressed patients in general practice

✍ D. B. Fairweather; N. Stanley; J. S. Yoon; I. Hindmarch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

The objective of this study was to assess whether there are any dierences between ¯uoxetine and dothiepin on cognitive function of patients with major depression (DSMIII-R). A randomized, double-blind, parallel group design, 6 week trial in patients in general practice was employed where patients we

Comparison of pramipexole, fluoxetine, a

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

✍ Mark H. Corrigan; Angelita Q. Denahan; C. Eugene Wright; Rhonda J. Ragual; Dwigh 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 1 views

Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,

Effectiveness of fluoxetine therapy in b

Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

✍ Goldstein, David J. ;Wilson, Michael G. ;Ascroft, Richard C. ;Al-Banna, Mahir 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 323 KB 👁 1 views

Objective: To evaluate fluoxetine efficacy in the treatment of bulimia nervosa patients with or without comorbid depression. Method: Two parallel, multicenter, doubleblind, randomized, placebo-controlled fluoxetine clinical trials were retrospectively analyzed to determine the effect of comorbid dep

Double-blind comparison of citalopram an

Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia

✍ Joseph Mendels; Ari Kiev; Louis F. Fabre 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## This multicenter study compared the efficacy and safety of citalopram and placebo in a population of moderately to severely depressed patients with melancholia. This randomized, double-blind, parallel-group study compared citalopram (flexible dose; 20-80 mg/day) with placebo in 180 psychiatric ou